ATE322891T1 - Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel - Google Patents
Arzneistoffabgabesystem für wasser schwerlösliche arzneimittelInfo
- Publication number
- ATE322891T1 ATE322891T1 AT01951278T AT01951278T ATE322891T1 AT E322891 T1 ATE322891 T1 AT E322891T1 AT 01951278 T AT01951278 T AT 01951278T AT 01951278 T AT01951278 T AT 01951278T AT E322891 T1 ATE322891 T1 AT E322891T1
- Authority
- AT
- Austria
- Prior art keywords
- water
- soluble drugs
- delivery system
- drug delivery
- hydrogels
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21662700P | 2000-07-07 | 2000-07-07 | |
| US25238900P | 2000-11-21 | 2000-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE322891T1 true ATE322891T1 (de) | 2006-04-15 |
Family
ID=26911183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01951278T ATE322891T1 (de) | 2000-07-07 | 2001-07-06 | Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030157171A1 (de) |
| EP (1) | EP1299089B1 (de) |
| JP (1) | JP2004502722A (de) |
| AT (1) | ATE322891T1 (de) |
| AU (1) | AU2001272262A1 (de) |
| BR (1) | BR0112258A (de) |
| CA (1) | CA2415081A1 (de) |
| DE (1) | DE60118742D1 (de) |
| IL (1) | IL153814A0 (de) |
| NO (1) | NO20030073L (de) |
| NZ (1) | NZ523418A (de) |
| WO (1) | WO2002003962A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050221501A1 (en) * | 2003-12-24 | 2005-10-06 | Arnot Kate I | Dissolution method |
| IL160095A0 (en) * | 2004-01-28 | 2004-06-20 | Yissum Res Dev Co | Formulations for poorly soluble drugs |
| US20060280791A1 (en) * | 2005-04-08 | 2006-12-14 | Ju Tzuchi R | Pharmaceutical formulations |
| EP1928473A4 (de) * | 2005-09-28 | 2009-11-18 | Dnp Canada Inc | Kombination aus polychitosamin und fibrat zur prävention und behandlung von hyperlipidämie |
| EP1942872A2 (de) * | 2005-11-04 | 2008-07-16 | Eastman Chemical Company | Carboxyalkylcelluloseester zur verabreichung von schwer löslichen pharmazeutischen wirkstoffen |
| KR20080108605A (ko) | 2006-04-05 | 2008-12-15 | 우드랜드 바이오퓨엘스 인크. | 합성 가스에 의해 바이오매스를 에탄올로 전환시키는 시스템 및 방법 |
| CA2682291C (en) * | 2007-04-19 | 2013-08-13 | Medovent Gmbh | Device made at least partially of n-acetylchitosan with controlled biodissolution |
| US9636309B2 (en) * | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
| US9750696B2 (en) | 2011-08-01 | 2017-09-05 | Sun Pharmaceutical Industries Limited | Dissolution enhanced controlled drug delivery system for poorly water soluble drugs |
| CN103315960A (zh) * | 2012-03-19 | 2013-09-25 | 胡容峰 | 基于球晶技术固体自微乳及其制备方法 |
| WO2019064231A1 (en) * | 2017-09-27 | 2019-04-04 | Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies (A4Tec) - Associação | HIGH MOLECULAR WEIGHT CHITOSAN, METHOD FOR PRODUCING THE SAME AND USES THEREOF |
| KR102407470B1 (ko) * | 2021-08-09 | 2022-06-10 | 인제대학교 산학협력단 | 하이드로겔에 담지된 약물의 방출량 검출 방법 |
| CN114515268B (zh) * | 2022-02-21 | 2024-06-21 | 上海宣泰医药科技股份有限公司 | 熊去氧胆酸药物组合物及其制备方法和药物制剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5620706A (en) * | 1995-04-10 | 1997-04-15 | Universite De Sherbrooke | Polyionic insoluble hydrogels comprising xanthan and chitosan |
| CA2243619A1 (fr) * | 1998-07-17 | 2000-01-17 | Universite De Sherbrooke | Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines |
-
2001
- 2001-07-06 CA CA002415081A patent/CA2415081A1/en not_active Abandoned
- 2001-07-06 JP JP2002508417A patent/JP2004502722A/ja not_active Withdrawn
- 2001-07-06 US US10/332,251 patent/US20030157171A1/en not_active Abandoned
- 2001-07-06 AT AT01951278T patent/ATE322891T1/de not_active IP Right Cessation
- 2001-07-06 AU AU2001272262A patent/AU2001272262A1/en not_active Abandoned
- 2001-07-06 WO PCT/CA2001/000993 patent/WO2002003962A2/en active IP Right Grant
- 2001-07-06 BR BR0112258-4A patent/BR0112258A/pt not_active IP Right Cessation
- 2001-07-06 EP EP01951278A patent/EP1299089B1/de not_active Expired - Lifetime
- 2001-07-06 IL IL15381401A patent/IL153814A0/xx unknown
- 2001-07-06 DE DE60118742T patent/DE60118742D1/de not_active Expired - Lifetime
- 2001-07-06 NZ NZ523418A patent/NZ523418A/en unknown
-
2003
- 2003-01-07 NO NO20030073A patent/NO20030073L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2415081A1 (en) | 2002-01-17 |
| NO20030073L (no) | 2003-03-06 |
| EP1299089A2 (de) | 2003-04-09 |
| DE60118742D1 (de) | 2006-05-24 |
| EP1299089B1 (de) | 2006-04-12 |
| BR0112258A (pt) | 2003-06-24 |
| NZ523418A (en) | 2004-09-24 |
| NO20030073D0 (no) | 2003-01-07 |
| WO2002003962A3 (en) | 2002-06-13 |
| US20030157171A1 (en) | 2003-08-21 |
| AU2001272262A1 (en) | 2002-01-21 |
| IL153814A0 (en) | 2003-07-31 |
| JP2004502722A (ja) | 2004-01-29 |
| WO2002003962A2 (en) | 2002-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE322891T1 (de) | Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel | |
| IS7286A (is) | Aðferðir til þess að mæla hæfi glatiramerasetats | |
| TWI256891B (en) | 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations | |
| MXPA02009275A (es) | Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos. | |
| HK1070063A1 (en) | Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments | |
| WO2001026693A3 (en) | Manufacture of polyglutamate-therapeutic agent conjugates | |
| SE9904505D0 (sv) | Novel compounds | |
| MXPA05012821A (es) | Formulacion farmaceutica que comprende un agente activo insoluble en agua. | |
| PL1643833T3 (pl) | Formulacje agrochemiczne | |
| HUP0401811A2 (hu) | Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására | |
| WO2004050057A3 (en) | An exopolysaccharides delivery system for active molecules | |
| EA200400455A1 (ru) | Способ приготовления быстрорастворимой дозировочной формы | |
| FI980862A0 (fi) | Kiraalisia metyylifenyylioksatsolidinoneja | |
| NO20014101L (no) | Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte | |
| DE69924004D1 (de) | Verabreichungssystem für wasserunlösliche arzneistoffe | |
| IL150528A0 (en) | Ibuprofen containing active agent preparation | |
| MXPA05011248A (es) | Derivados de wortmanina solubles en agua. | |
| TW200517144A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
| ATE318281T1 (de) | Lösungsmittelverklebungsverfahren | |
| WO2003041656A3 (en) | Soluble drug extended release system | |
| CA2407795A1 (en) | Fluorescein isothiocyanate (fitc) sinistrin, its production and use | |
| CY1111960T1 (el) | Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων | |
| AU7599900A (en) | Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles | |
| AU2003256882A1 (en) | Methods of drug delivery using sulphated chitinous polymers | |
| SE9902742D0 (sv) | New pharmaceutical formultion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |